Work

Su1859 UPFRONT RESECTION VS NEOADJUVANT CHEMOTHERAPY FOR PATIENT WITH UPFRONT RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA AND LOW CARBOHYDRATE ANTIGEN 19-9 LEVELS

Year: 2026

Type: conference-abstract

Source: Gastrointestinal Endoscopy

DOI: 10.1016/s0016-5107(26)05156-4

Authors: Po Hong Tan, Dillon C. Cheung, Stephanie Yu, Chee-Chee Stucky, Richard Max Miller, Hoe Yan Hor, Melody Pi Yin Tu, Daniel Alif, Richard Bold, Nabil Wasif, Zhi Ven Fong

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160029838

Cites:

Cited by:

Related to: 10